pe
pep-05221 v1 CC-BY-SA-4.0

CarS anticancer peptide

A lab-made peptide being studied for its potential to fight cancer cells; experimental, not yet an approved drug.

statusbioassayed targetANTICANCER length58 aa refs1
anticancer
EARLY ENTRY This candidate is newly indexed — supporting evidence is still being added. Have a paper or data point? Contribute below.
status 2 / 5 · 0 verified on platform
prediction metrics boltz-2 2.2.1
ipTM0.000
pTM0.619
avg pLDDT83.2
ranking score0.790
STRUCTURE · PEP-05221 × ANTICANCER
ranking0.790
?
RECEPTOR UNKNOWN
peptide conformation only · no target structure
target interface 4.5Å peptide drag rotate · ctrl+scroll zoom · right-click pan
sequence58 aa
151015202530354045505558
IYWIADQFGIHLATGTARKL LDAVASGASLGTAFAAILGV TLPAWALAAAGALGATAA
in the news 27 articles
details expand to inspect
full evidence table1 metrics
metricvaluetool
ranking score 0.7895351648330688 boltz-2
3-letter notation
Ile-Tyr-Trp-Ile-Ala-Asp-Gln-Phe-Gly-Ile-His-Leu-Ala-Thr-Gly-Thr-Ala-Arg-Lys-Leu-Leu-Asp-Ala-Val-Ala-Ser-Gly-Ala-Ser-Leu-Gly-Thr-Ala-Phe-Ala-Ala-Ile-Leu-Gly-Val-Thr-Leu-Pro-Ala-Trp-Ala-Leu-Ala-Ala-Ala-Gly-Ala-Leu-Gly-Ala-Thr-Ala-Ala
recipeboltz-2 2.2.1
parametervalue
modelboltz-2 2.2.1
weights
hardwarevast_v100_32gb
mlx version
python
random seed1
msa strategynone_monomer
runtime
predicted by
predicted at2026-05-23
citationbibtex
peptidemodel (2026). CarS anticancer peptide (pep-05221, v1). PeptideModel. https://peptidemodel.com/card/pep-05221
@peptide{pep05221,
  sequence = {IYWIADQFGIHLATGTARKLLDAVASGASLGTAFAAILGVTLPAWALAAAGALGATAA},
  target   = {anticancer},
  author   = {peptidemodel},
  year     = {2026},
  status   = {bioassayed}
}
related peptides 3 by signal overlap
references 1 papers
discussion no comments
sign in to comment
peptidemodel.com CC-BY-SA-4.0 research only · not for human use